Para-Chlorophenylpiperazine

From WikiMD's WELLNESSPEDIA

Para-Chlorophenylpiperazine (pCPP) is a psychoactive drug and research chemical of the piperazine chemical class that has been sold online as a designer drug. It is a metabolite of the antidepressant drugs trazodone and nefazodone.

Chemistry[edit]

pCPP is a derivative of phenylpiperazine, a type of piperazine, and is chemically related to other drugs that have an aromatic phenyl ring attached to a piperazine core. A piperazine is a type of organic compound that contains a six-membered ring containing two nitrogen atoms at opposite positions in the ring. pCPP is classified as a substituted piperazine.

Pharmacology[edit]

pCPP acts as a serotonin receptor agonist, which means it increases the activity of the serotonin system in the brain. Serotonin is a neurotransmitter that is involved in the regulation of mood, appetite, and sleep. pCPP is also a partial agonist of the 5-HT2C receptor, which is involved in the regulation of mood and appetite.

Effects[edit]

The effects of pCPP on the human brain are not fully understood. However, it is known to produce psychoactive effects similar to those of other stimulant drugs. These effects may include feelings of euphoria, increased energy, and altered perceptions. It may also cause side effects such as anxiety, restlessness, and insomnia.

Legal Status[edit]

The legal status of pCPP varies by country. In some countries, it is a controlled substance, which means its manufacture, distribution, and use are regulated by law. In other countries, it is not controlled, but may be considered a research chemical, which means it is not approved for medical use and is often sold online for research purposes.

See Also[edit]


This article is a stub related to chemistry. You can help WikiMD by expanding it!


```

Para-Chlorophenylpiperazine[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.